News – Page 494 – Endpoints News

SIGN UP

Axsome's long delayed depression drug is back up for label discussions at the FDA, triggering a big spike in the ...

3 years ago

Basilea tosses an oncology drug back to Merck, doubling down on antibiotics in revamp

3 years ago

Charles River Laboratories to start cell and gene therapy manufacturing at UK site in September

3 years ago

Europe to buy 110k doses of Bavarian Nordic's monkeypox vaccine — as EU-licensed vaccine not easily accessible

3 years ago

CVS resumes coverage of blockbuster blood thinner after price drop follows January exclusion

3 years ago

#CannesLions2022: Consumer health execs call on agencies to involve patients in creative process

3 years ago

#CannesLions2022 MarketingRx roundup: Pharma and health finalists packed in back of Palais basement displays; Ryan ...

3 years ago

Novartis details plans to axe 8,000 staffers as Narasimhan begins second phase of a global reorg

3 years ago

Graybug seeks alternative options for eye drugs; RA-backed epilepsy outfit secures $40M Series C

3 years ago

Jazz reports surprise PhIII flop for cannabinoid drug from $7.2B GW buyout

3 years ago

#CannesLions2022: Pharma and health marketers lose spotlight at creativity ad fest, but does it matter?

3 years ago

#CannesLions2022: Diversity, equity and inclusion takes center stage as pharma industry is called to action

3 years ago

Spero’s UTI candidate gets the CRL hammer as the company falls into penny stock status

3 years ago

A decade after its first approval, FDA expands weight loss pill's label for use in adolescents

3 years ago

Four months after CRL due to contaminant worries, Gilead returns to FDA for next-gen HIV drug

3 years ago

Years after linking arms with Bristol Myers and both Mercks, Sutro finds its latest partner in Tokyo

3 years ago

Scoop: Roche scraps one of two schizophrenia PhII trials after failing the primary endpoint

3 years ago

Pharma group bets up to $1B-plus on the PhIII resurrection of a once dead-and-buried LDL drug

3 years ago

Roivant chops sickle cell gene therapy, dermatology drugs to focus on 'higher value projects'

3 years ago

How prepared is biopharma for the cyber doomsday?

3 years ago

Still in preclinical testing for ear gene therapies, Decibel touts small snapshot of chemo-induced hearing loss drug

3 years ago

Longtime biotech leader Pearl Huang takes the reins as CEO of Novartis-backed upstart

3 years ago

Roivant unveils latest spinout as Pfizer entrusts JAK1/TYK2 to Priovant

3 years ago

Alexion puts €65M forward to strengthen its position on the Emerald Isle

3 years ago

First page Previous page 491 492 493494495 496 497 Next page Last page